 ROSELAND, N.J., June 07, 2021 GLOBE NEWSWIRE -- RenovaCare, Inc. Symbol: RCAR; today announced that it is initiating a clinical trial at four burn centers in the United States. This follows the Companys recent Investigational Device Exemption IDE approval by the U.S. Food and Drug Administration FDA. 